InvestorsHub Logo
Followers 7
Posts 864
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Friday, 01/18/2019 1:32:20 PM

Friday, January 18, 2019 1:32:20 PM

Post# of 73113
The three products that I am aware of are Tetracycline (Vitastem), Prolayed, and CBD. If our licensed transdermal technology does offer enhanced drug delivery then sales would likely follow. Do we have an exclusive license or can Phillips license it to other competitors? How long does our license stay in force?

Beauty products for women’s skin could be another market. CBD for joint pain might require deep penetration.